The Boston startup uses AI to translate and verify legacy software for defense contractors, arguing modernization can’t come at the cost of new bugs.
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results